Overview

• GE Healthcare is working with advisers on scenarios that include bringing in a local partner, selling a minority stake, or divesting the entire unit, according to Bloomberg and Reuters.
• A potential transaction could value the China operations in the billions of dollars, but discussions are preliminary and no decisions have been made.
• The company declined to address the specifics of the report and said it does not respond to market rumors while affirming its commitment to patients in China.
• Shares rose about 1.4% in premarket trading after the reports.
• GE Healthcare has six manufacturing sites in China and has been working with suppliers to shift capacity to more tariff-friendly locations, its CFO said in July.